Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Enlivex Therapeutics stock
Learn how to easily invest in Enlivex Therapeutics stock.
Enlivex Therapeutics Ltd is a biotechnology business based in the US. Enlivex Therapeutics shares (ENLV) are listed on the NASDAQ and all prices are listed in US Dollars. Enlivex Therapeutics employs 71 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Enlivex Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ENLV – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Enlivex Therapeutics stock price (NASDAQ: ENLV)Use our graph to track the performance of ENLV stocks over time.
Enlivex Therapeutics shares at a glance
|Latest market close||$4.30|
|52-week range||$3.65 - $9.85|
|50-day moving average||$4.87|
|200-day moving average||$5.19|
|Wall St. target price||$15.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.07|
Buy Enlivex Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Enlivex Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Enlivex Therapeutics price performance over time
|1 week (2022-09-29)||3.86%|
|1 month (2022-09-06)||-14.00%|
|3 months (2022-07-06)||-7.53%|
|6 months (2022-04-06)||-50.23%|
|1 year (2021-10-06)||-55.49%|
|2 years (2020-10-06)||-70.34%|
|3 years (2019-10-04)||10.35|
|5 years (2017-10-06)||94.57%|
Enlivex Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-17.35%|
|Return on equity TTM||-33.14%|
|Market capitalisation||$77.2 million|
TTM: trailing 12 months
Enlivex Therapeutics share dividends
We're not expecting Enlivex Therapeutics to pay a dividend over the next 12 months.
Have Enlivex Therapeutics's shares ever split?
Enlivex Therapeutics's shares were split on a 1:8 basis on 6 March 2019. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Enlivex Therapeutics shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Enlivex Therapeutics shares which in turn could have impacted Enlivex Therapeutics's share price.
Enlivex Therapeutics share price volatility
Over the last 12 months, Enlivex Therapeutics's shares have ranged in value from as little as $3.65 up to $9.85. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Enlivex Therapeutics's is 0.4143. This would suggest that Enlivex Therapeutics's shares are less volatile than average (for this exchange).
Enlivex Therapeutics overview
Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel. .
Enlivex Therapeutics in the news
Enlivex to Present at the 4th Macrophage-Directed Therapies Summit
Enlivex to Present at the 4th Macrophage-Directed Therapies Summit
Enlivex to Present at Upcoming Investor and Media Conferences
Frequently asked questionsWhat percentage of Enlivex Therapeutics is owned by insiders or institutions?
Currently 12.219% of Enlivex Therapeutics shares are held by insiders and 11.004% by institutions. How many people work for Enlivex Therapeutics?
Latest data suggests 71 work at Enlivex Therapeutics. When does the fiscal year end for Enlivex Therapeutics?
Enlivex Therapeutics's fiscal year ends in December. Where is Enlivex Therapeutics based?
Enlivex Therapeutics's address is: 14 Einstein Street, Ness Ziona, Israel, 7403618 What is Enlivex Therapeutics's ISIN number?
Enlivex Therapeutics's international securities identification number is: IL0011319527 What is Enlivex Therapeutics's CUSIP number?
Enlivex Therapeutics's Committee on Uniform Securities Identification Procedures number is: M20156101
More guides on Finder
How to invest in dividend stocks
How to add dividend stocks to your portfolio, and what to consider before you get started.
How to buy OTC stocks
Find out how to buy OTC stocks and compare brokers who offer access to OTC Markets.
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Invest in FAANG stocks
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Ask an Expert